Skip to main content
Premium Trial:

Request an Annual Quote

Solexa Added To Russell 3000 Index

NEW YORK (GenomeWeb News) - Solexa has been added to the Russell 3000 Index, which measures the performance of the 3,000 largest US companies based on total market capitalization, the company said today.
 
Inclusion in the index "should increase Solexa's visibility with institutions that rely on it as part of their investment strategy," said John West, Solexa CEO, in a statement.
 
Solexa's market cap is currently $324 million.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.